AJP - Endo AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 267: E990-E1001, 1994;
0193-1849/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slater, M.
Right arrow Articles by Mason, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slater, M.
Right arrow Articles by Mason, R. S.

AJP - Endocrinology and Metabolism, Vol 267, Issue 6 E990-1001, Copyright © 1994 by American Physiological Society


ARTICLES

Modulation of growth factor incorporation into ECM of human osteoblast-like cells in vitro by 17 beta-estradiol

M. Slater, J. Patava, K. Kingham and R. S. Mason
Department of Physiology, University of Sydney, New South Wales, Australia.

Human fetal osteoblast-like cells formed a regular multilayered structure in vitro with an extensive collagen-based extracellular matrix. With colloidal gold immunocytochemistry, labels for alkaline phosphatase and osteocalcin were distributed in a relatively diffuse pattern, in contrast to the bone growth factors, insulin-like growth factors I and II (IGF-I and IGF-II), transforming growth factor-beta 1 (TGF-beta 1), and basic fibroblast growth factor, which were colocalized in the collagenous matrix of the multilayer. The inclusion of 17 beta-estradiol (10(-11) to 10(-9) M) in the culture medium increased multilayer depths, increased labeling for IGF-I, IGF-II, and TGF-beta 1, and resulted in earlier detection of TGF-beta 1 label. In contrast, the increase in multilayer depth resulting from treatment with human platelets, an exogenous source of growth factors, was not accompanied by an increase in matrix IGF-I, IGF-II, or TGF-beta 1 label, suggesting a particular effect of estradiol to facilitate this process. Because growth factors in bone matrix may act as coupling agents when released during resorption, reduced growth factor incorporation in the presence of reduced sex steroid concentrations may lead to uncoupling of resorption and subsequent formation.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. A. Crofts, M. S. Hancock, N. A. Morrison, and J. A. Eisman
Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts
PNAS, September 1, 1998; 95(18): 10529 - 10534.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Takeshita, K. Imai, S. Kato, S. Kitano, and S. Hanazawa
1alpha ,25-Dehydroxyvitamin D3 Synergism toward Transforming Growth Factor-beta 1-induced AP-1 Transcriptional Activity in Mouse Osteoblastic Cells via Its Nuclear Receptor
J. Biol. Chem., June 12, 1998; 273(24): 14738 - 14744.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online